HemaSphere (Jun 2022)

P1545: DURABILITY OF HEMOGLOBIN RESPONSE AND REDUCTION IN TRANSFUSION BURDEN IS MAINTAINED OVER TIME IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT IN A LONG-TERM EXTENSION STUDY

  • R. F. Grace,
  • A. Glenthøj,
  • W. Barcellini,
  • M. Verhovsek,
  • J. A. Rothman,
  • M. Morado Arias,
  • D. M. Layton,
  • O. Andres,
  • F. Galactéros,
  • E. J. van Beers,
  • K. Onodera,
  • V. Viprakasit,
  • S. Chonat,
  • J. B. Porter,
  • M. P. Judge,
  • P. A. Kosinski,
  • P. Hawkins,
  • S. Gheuens,
  • R. Xu,
  • B. McGee,
  • V. Beynon,
  • H. Al-Samkari

DOI
https://doi.org/10.1097/01.HS9.0000849036.11558.e5
Journal volume & issue
Vol. 6
pp. 1426 – 1427

Abstract

Read online

No abstracts available.